ARTV

Artiva Biotherapeutics
ARTV

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$21
333% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wedbush
Wedbush
Martin Fan
50% 1-yr ARTV win rate
17 Oct ‘25 11 days ago
Needham
Needham
Gil Blum
40% 1-yr ARTV win rate
17 Oct ‘25 11 days ago